Brief: Valbiotis Obtains The European Patent For VALEDIA

Valbiotis SA

11/02/2019 16:51

Feb 11 (Reuters) - VALBIOTIS SAS  ALVAL.PA :
    * VALBIOTIS OBTAINS THE EUROPEAN PATENT FOR VALEDIA®
    * GUARANTEED EXCLUSIVITY ON PREDIABETES AND METABOLIC
DISEASES
MARKET IN 38 COUNTRIES ACROSS EUROPE, INCLUDING EUROPEAN UNION
    * VALEDIA NOW HOLDS INDUSTRIAL PROPERTY RIGHTS FOR TWO MAJOR
GLOBAL MARKETS: EUROPE AND UNITED STATES
    * THIS PATENT GUARANTEES EXCLUSIVE EXPLOITATION RIGHTS OF
VALEDIA®
UNTIL 2035 IN EUROPE, INCLUDING 28 COUNTRIES OF EUROPEAN UNION.
    * TOTUM-63 PATENT IS CO-OWNED WITH CNRS (FRENCH NATIONAL
CENTER
FOR SCIENTIFIC RESEARCH)

Source text for Eikon:  ID:nBw5dfR29a 
Further company coverage:  ALVAL.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))